LanzaTech

Photo

LanzaTech, Seksui to Develop Waste-to-Ethanol Plants in Japan

US green technology firm LanzaTech has signed an agreement with Sekisui Chemical to deploy, at commercial scale, a jointly developed platform that converts syngas derived from municipal solid waste (MSW) and industrial solid waste into ethanol. Sekisui intends to build multiple facilities in municipalities across Japan which incorporate equipment packages, engineering and advisory services, consumables, and intellectual property provided by LanzaTech, the companies said.

Photo

LanzaTech Goes Public with AMCI Merger

LanzaTech is entering the public market by merging with special purpose acquisition company (SPAC) AMCI Acquisition Corp. II. The transaction, which is expected to close in the third quarter of 2022, will make it the first carbon capture and transformation company to access the public capital markets, LanzaTech said.

Photo

LanzaTech Converts Carbon into Ethanol, Acetone/IPA

LanzaTech and carbon technology firm Twelve have created ethanol from CO2 emissions as part of an ongoing research and development partnership. The process uses Twelve’s carbon transformation technology and LanzaTech’s small continuous stirred tank reactor in an approach that the companies said is highly scalable to industrial quantities, while simultaneously eliminating CO2 emissions.

Photo

LanzaTech and Twelve Partner on PP from CO2

US green technology firm LanzaTech is collaborating with compatriot company Twelve, with the two combining their platform technologies to develop what they said would be the world’s first PP made from CO2 emissions.

Photo

TechnipFMC and LanzaTech in Hummingbird Deal

TechnipFMC has announced the first commercial application of its Hummingbird sustainable ethanol-to-ethylene technology, following a licensing deal with LanzaTech. The engineering contractor originally acquired the process from BP Chemicals in June 2016.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.